Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase

Abstract

MMAC1, also known as PTEN or TEP-1, was recently identified as a gene commonly mutated in a variety of human neoplasias. Sequence analysis revealed that MMAC1 harbored sequences similar to those found in several protein phosphatases. Subsequent studies demonstrated that MMAC1 possessed in vitro enzymatic activity similar to that exhibited by dual specificity phosphatases. To characterize the potential cellular functions of MMAC1, we expressed wild-type and several mutant variants of MMAC1 in the human glioma cell line, U373, that lacks endogenous expression. While expression of wild-type MMAC1 in these cells significantly reduced their growth rate and saturation density, expression of enzymatically inactive MMAC1 significantly enhanced growth in soft agar. Our observations indicate that while wild-type MMAC1 exhibits activities compatible with its proposed role as a tumor suppressor, cellular expression of MMAC1 containing mutations in the catalytic domain may yield protein products that enhance transformation characteristics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Baker BW, Boettiger D, Spooner E and Norton JD. . 1992 Nuc. Acids Res. 20: 5234.

  • Cheney IW, Johnson DE, Vaillancourt M-T, Avanzini J, Morimoto A, Demers WG, Wills KN, Shabram PW, Bolen JB, Tavtigian SV and Bookstein R. . 1998 Cancer Res. 58: 2331–2334.

  • Furnari FB, Lin H, Su Huang H-J and Cavenee WK. . 1997 Proc. Natl. Acad. Sci. USA 94: 12479–12484.

  • Guldgerg P, Straten P-T, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J. . 1997 Cancer Res. 57: 3660–3663.

  • Kong D, Suzuki A, Zou T-T, Sakurada A, Kemp LW, Wakatsuki S, Yokohama T, Yamakawa H, Furukawa T, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A. . 1998 Nature Genet. 17: 143–144.

  • Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R. . 1997 Nature Genet. 16: 64–67.

  • Li D-M and Sun H. . 1997 Cancer Res. 57: 2124–2129.

  • Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. . 1997 Science 275: 1943–1947.

  • Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ and Eng C. . 1997 Nat. Genet. 16: 333–334.

  • Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R and Tonks NK. . 1998 Proc. Natl. Acad. Sci. USA 94: 9052–9057.

  • Neel BG and Tonks NK. . 1997 Curr. Opin. Cell Biol. 9: 193–204.

  • Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL, Gorman DM, Nolan GP, Miyajima A and Kitamura T. . 1997 Exp. Hematol. 24: 324–329.

  • Pawson T and Scott JD. . 1997 Science 278: 2075–2080.

  • Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA and Thomas G. . 1998 Science 279: 707–710.

  • Saras J and Heldin C-H. . 1996 Trends in Bioch. Sci. 21: 455–457.

  • Shiozaki K and Russell P. . 1995 Nature 378: 739–743.

  • Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swelund B, Teng DHF and Tavtigian SV. . 1997 Nature Genet. 15: 356–362.

  • Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PRJ, Reese CB, McCormick F, Tempst P, Coadwell J and Hawkins PT. . 1998 Science 279: 710–714.

  • Sun H, Charles CH, Lau LF and Tonks NK. . 1993 Cell 75: 487–493.

  • Tamura M, Gu J, Marsumoto K, Aota S, Parsons R and Yamada KM. . 1998 Science 280: 1614–1617.

  • Teng DH-F, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncosco P, Yung WKA, Fujii G, Berson A, Bookstein R, Bolen JB, Tavtigian SV and Steck PA. . 1997 Cancer Res. 57: 5221–5225.

Download references

Acknowledgements

We thank B Wu, C Young and J Sheung for generating purified recombinant MMAC1 protein. We would also like to thank J-H Her, A Mui, D Parry, M Tomlinson, D Woods, R Herbst and M McMahon for reagents and very helpful suggestions. The DNAX Research Institute is supported by the Schering-Plough Corporation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morimoto, A., Berson, A., Fujii, G. et al. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase. Oncogene 18, 1261–1266 (1999). https://doi.org/10.1038/sj.onc.1202441

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202441

Keywords

This article is cited by

Search

Quick links